COVID-19 Second Wave
Showing 1 - 25 of >10,000
Covid19, Comorbidities and Coexisting Conditions, Risk Factor, Cardiovascular Trial in Moscow
Completed
- Covid19
- +8 more
-
Moscow, Russian FederationEurasian Association of Therapists
Feb 1, 2022
The Second COVID-19 Wave: Collateral Impact on Patients of Liver
Completed
- Liver Diseases
- This is an observational study
-
New Delhi, Delhi, IndiaInstitute of Liver & Biliary Sciences
Dec 31, 2021
COVID-19 on Pediatric Dental Practice During First, Second And
Recruiting
- SARS-CoV2
-
Cairo, EgyptFaculty of Oral and Dental Medicine, Cairo University
Jun 11, 2021
Ventilation Associated Pneumonia and Covid-19
Completed
- SARS-CoV2 Infection
- +3 more
-
Nîmes Cedex 09, FranceCHU de Nîmes - Hôpital Universitaire Carémeau
Oct 21, 2021
Extrapulmonary Presentations of COVID-19 Patients
Recruiting
- COVID-19
-
Sohag, EgyptSohag University
May 20, 2021
Epidemic and Neuroimaging for Patients During 1st Wave of
Recruiting
- COVID-19
- +3 more
- Simultaneous cortico-spinal magnetic resonance imaging, Serum
-
Xi'an, Shaanxi, ChinaFirst Affiliated Hospital of Xian Jiaotong University
Feb 24, 2023
Physiotherapy in Critically Ill Covid Patients
Recruiting
- COVID-19
-
Barcelona, SpainHospital de la Santa Creu i Sant Pau
Sep 14, 2023
COVID-19 Trial in Nanjing (Intramuscularly administered Ad5-nCoV vaccine, Aerosolized Ad5-nCoV, DelNS1-2019-nCoV-RBD-OPT1)
Not yet recruiting
- COVID-19
- Intramuscularly administered Ad5-nCoV vaccine
- +3 more
-
Nanjing, Jiangsu, ChinaJiangsu Provincial Center for Disease Control and Prevention
May 10, 2023
Knowledge and Attitude ofGroup of Egyptian Parents Toward Dental
Not yet recruiting
- COVID-19 Pandemic
- (no location specified)
Jun 5, 2022
Musculoskeletal Pain in Covid-19 Who Have Hospital Care
Not yet recruiting
- Covid19
- Interview
-
Milan, ItalyJorge Hugo Villafañe
Nov 17, 2020
COVID-19, Endothelial Function, Diastolic Dysfunction Trial in Moscow (Portable cardiac monitor "CardioQvark", Cardiorespiratory
Recruiting
- COVID-19
- +5 more
- Portable cardiac monitor "CardioQvark"
- +2 more
-
Moscow, Russian FederationI.M. Sechenov First Moscow State Medical University (Sechenov Un
Nov 5, 2022
SSC-COVID in Patients After COVID-19
Completed
- Secondary Sclerosing Cholangitis
- COVID-19
- control of liver enzymes
-
Tuebingen, GermanyUniversity Hospital of Tuebingen
Feb 9, 2022
Oxford-AstraZeneca COVID-19 Vaccine as2nd Booster,
Recruiting
- COVID-19
- ChAdOx1 nCOV-19 vaccine (Vaxzeria)
- +3 more
-
São Paulo, BrazilTechtrials Pesquisa e Tecnologia Ltda.
Jan 23, 2023
Effect of a Third COVID-19 Booster Among Health Care Workers
Not yet recruiting
- COVID-19 Vaccines
- Third COVID-19 booster
-
Hong Kong, Hong KongHong Kong Sanatorium & Hospital
May 16, 2022
Moderna COVID-19 Bivalent Booster for Omicron BA.4/5
Recruiting
- COVID-19
- Moderna COVID-19 Vaccine
- +3 more
-
Culver City, CaliforniaScience37
Mar 9, 2023
During Weaning From Mechanical Ventilation in COVID-19 Patients
Recruiting
- Weaning
- +3 more
- Point-of-Care Ultrasound
-
Hangzhou, Zhejiang, ChinaThe Second Affiliated Hospital of Zhejiang University anesthesio
Jan 29, 2023
Postoperative Complications, Morality Trial in Xi'an (In-Hospital COVID-19 Omicron Infection after surgery)
Completed
- Postoperative Complications
- Morality
- In-Hospital COVID-19 Omicron Infection after surgery
-
Xi'an, Shannxi, ChinaThe Second Affiliated Hospital of Air Force Medical University U
Sep 8, 2023
COVID-19, Chronic Heart Failure, Diabetes Trial in Moscow
Recruiting
- COVID-19
- +18 more
-
Moscow, Russian FederationEurasian Association of Therapists
Jul 30, 2022
Preoperative Anxiety During COVID-19
Completed
- Anxiety
- Pandemic, COVID-19
- mPAS questionnaire
-
Larissa, Thessaly, GreeceUniveristy of Thessaly
Feb 9, 2022
Systemic Allergic Reaction Trial run by the NIAID (Pfizer-BioNTech COVID-19 Vaccine (comirnaty), Placebo)
Active, not recruiting
- Systemic Allergic Reaction
- Pfizer-BioNTech COVID-19 Vaccine (comirnaty)
- Placebo
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jul 23, 2022
Prevention of COVID-19 Caused by SARS-CoV-2 Trial in Chengdu (randomized, double-blinded, -controlled)
Active, not recruiting
- Prevention of COVID-19 Caused by SARS-CoV-2
- randomized, double-blinded, placebo-controlled
-
Chengdu, ChinaWest China Second University Hospital
Jan 9, 2023
COVID-19 Trial in Guangzhou, Shenzhen, Shijiazhuang (SHEN26 dose 1, SHEN26 dose 2, SHEN26 )
Recruiting
- COVID-19
- SHEN26 dose 1
- +2 more
-
Guangzhou, Guangdong, China
- +3 more
Jan 4, 2023
COVID-19 Trial in Hohhot (Graphene spectrum light wave therapy room)
Recruiting
- COVID-19
- Graphene spectrum light wave therapy room
-
Hohhot, Inner Mongolia, ChinaHohhot First Hospital
Dec 7, 2022
Covid19 Trial in Pavia (hyperimmune plasma)
Active, not recruiting
- Covid19
- hyperimmune plasma
-
Pavia, ItalyCatherine Klersy
Mar 30, 2022